Literature DB >> 1871765

The two major subtypes of HLA-B44 differ for a single amino acid in codon 156.

K Fleischhauer1, N A Kernan, B Dupont, S Y Yang.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1871765     DOI： 10.1111/j.1399-0039.1991.tb01859.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN： 0001-2815


× No keyword cloud information.
  7 in total

1.  Nomenclature for factors of the HLA system, 1991. The WHO Nomenclature Committee for factors of the HLA system.

Authors: 
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Molecular analysis of HLA-B39 subtypes.

Authors:  N Kato; S Karaki; K Kashiwase; C Müller; T Akaza; T Juji; K Kano; M Takiguchi
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

3.  A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia.

Authors:  H Dolstra; H Fredrix; F Maas; P G Coulie; F Brasseur; E Mensink; G J Adema; T M de Witte; C G Figdor; E van de Wiel-van Kemenade
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

4.  A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3.

Authors:  J Herman; P van der Bruggen; I F Luescher; S Mandruzzato; P Romero; J Thonnard; K Fleischhauer; T Boon; P G Coulie
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

5.  An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.

Authors:  S R Burrows; R Khanna; J M Burrows; D J Moss
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

6.  NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80.

Authors:  M Cella; A Longo; G B Ferrara; J L Strominger; M Colonna
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

7.  Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion.

Authors:  Danielle Zernich; Anthony W Purcell; Whitney A Macdonald; Lars Kjer-Nielsen; Lauren K Ely; Nihay Laham; Tanya Crockford; Nicole A Mifsud; Mandvi Bharadwaj; Linus Chang; Brian D Tait; Rhonda Holdsworth; Andrew G Brooks; Stephen P Bottomley; Travis Beddoe; Chen Au Peh; Jamie Rossjohn; James McCluskey
Journal:  J Exp Med       Date:  2004-06-28       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.